About products, innovations and the company

Our parent company reveals its new name and brand

As the capstone in a multi-year transformation process, on May 9th, our parent company unveiled its new name and brand – Revvity.

Novel autoantibody against septin-3 discovered in neurological disease

The cytoskeleton protein septin-3 has been identified as a novel target antigen of autoantibodies in patients with paraneoplastic cerebellar ataxia. The new biomarker was discovered in a collaborative ...

Computer-aided classification of IIF patterns in autoimmune dermatoses

Deep neural networks incorporating segmentation provide highly accurate classification of immunofluorescence patterns on the tissue substrates esophagus and salt-split skin for detection of autoimmune ...

Indirect immunofluorescence microscopy using our IVDR-compliant EUROStar III Plus

Microscopy is a fundamental tool in biomedical research and clinical diagnostics. However, each laboratory has different requirements for its instruments: While laboratories with a low sample ...

PLA2R, an important marker for pMN diagnostics - EUROIMMUN test systems

NEW Video!

Recombinant ELISAs increase efficiency of CMV serodiagnosis in pregnant women

EUROIMMUN ELISAs based on recombinant antigens p52 (IgM) and glycoprotein B (IgG) from cytomegalovirus (CMV) provided a higher rate of conclusive results in first-line testing of samples from pregnant ...

Reliable detection of anti-CCHFV antibodies in acute infections

EUROIMMUN ELISAs for detection of antibodies against Crimean-Congo haemorrhagic fever virus (CCHFV) reliably identify acute CCHF cases and are suitable for laboratories involved in on-site outbreak ...

Automated IIFT diagnostics in the hospital routine

Indirect immunofluorescence diagnostics is one of EUROIMMUN’s long-standing areas of expertise, at least since the introduction of the then ground-breaking BIOCHIP technology in 1983. In the ...

Changes in the EUROIMMUN Executive Board

With the start of the new year, EUROIMMUN Medizinische Labordiagnostika AG, a PerkinElmer, Inc. company, announces changes in its executive board. Dirk Beecker, who has been the company’s chief ...

Our 1000th EUROBlotOne: More capacities through automation

New year, same challenges: There is a shortage of laboratory specialists, which has been brought into the spotlight by the pandemic. For many of them, urgent emails and the need to prioritise analyses ...

Back to top
Contact person on site
Please click on a country or enter yours
North America
South & Central America
Middle East & Africa